Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Chengdu Big Data Association | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
The study aims to investigate the clinical characteristics, treatment, and economic burden of disease of Chinese diabetic/non-diabetic patients with/without established cardiovascular disease (CVD), chronic kidney disease (CKD), or at high cardiovascular risk, including:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| In- and outpatients: diabetic with risk factors (RF) [Arm A] | In- and outpatients with diagnosis of diabetes, and with diagnosis of risk factors cardiovascular disease (CVD), heart failure (HF), chronic kidney disease (CKD) or at high cardiovascular (CV) risk identified in the Tianjin regional medical database. | ||
| In- and outpatients: diabetic without RF [Arm B] | In- and outpatients with diagnosis of diabetes, but not with diagnosis of risk factors CVD, HF, CKD or at high CV risk identified in the Tianjin regional medical database. | ||
| In- and outpatients: non-diabetic with RF [Arm C] | In- and outpatients without diabetes but with diagnosis of risk factors CVD, HF, CKD or at high CV risk identified in the Tianjin regional medical database. | ||
| In- and outpatients: non-diabetic without RF [Arm D] | In- and outpatients without diabetes and without diagnosis of risk factors CVD, HF, CKD or at high CV risk identified in the Tianjin regional medical database. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants With Established Cardiovascular Disease, or Chronic Kidney Disease, or High Cardiovascular Risk | Number of participants with established cardiovascular disease (CVD), chronic kidney disease (CKD), and/or high cardiovascular (CV) risk was calculated as (100%* Number of patients with labels of interested diseases from 2015 to the given year)/ (Number of diabetic or non-diabetic patients from 2015 to the given year). To compare diabetic with non-diabetic patients within a year and across years
Patients with risk factors were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | up to 5 years (2015 up to 2019) |
| Measure | Description | Time Frame |
|---|---|---|
| Mean Age of Inpatients and All Participants (In-and Outpatients) at Their Last Visit in 2015 | The mean age was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2015. The Arms A, B, C, D - inpatients only were mutually exclusive in 2015. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. |
Not provided
Inclusion Criteria:
Definition of diabetes, cardiovascular disease, chronic kidney disease and high cardiovascular risk:
Exclusion Criteria:
Not provided
Not provided
Not provided
Diabetic/non-diabetic patients with/without established cardiovascular disease, chronic kidney disease, or at high cardiovascular risk.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chengdu Big Data Association | Chengdu | 610041 | China |
Not provided
| Label | URL |
|---|---|
| Related Info | View source |
Not provided
Clinical studies sponsored by Boehringer Ingelheim, phases I to IV, interventional and non-interventional, are in scope for sharing of the raw clinical study data and clinical study documents. Exceptions might apply, e.g. studies in products where Boehringer Ingelheim is not the license holder; studies regarding pharmaceutical formulations and associated analytical methods, and studies pertinent to pharmacokinetics using human biomaterials; studies conducted in a single center or targeting rare diseases (in case of low number of patients and therefore limitations with anonymization).
For more details refer to: https://www.mystudywindow.com/msw/datatransparency
Not provided
Not provided
Not provided
Not provided
Only participants that met all inclusion and none of the exclusion criteria were included. Participants with at least 1 diagnosis record and baseline information (birth date and sex) were identified in the Tianjin regional medical database between 01/01/2015 to 31/12/2019 and allocated in 4 (A,B,C, and D) arms. The 4 arms were mutually exclusive in each year (2015, 2017, and 2019) but not across years.
This observational, cross-sectional study, based on routinely collected data captured in the regional, electronic, data-linking Tianjin medical database between 01/01/2015 and 31/12/2019 aimed to investigate the clinical characteristics, treatment, and economic burden of disease of Chinese diabetic/non-diabetic patients with/without established cardiovascular disease, chronic kidney disease, or high cardiovascular risk.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | In- and Outpatients: Diabetic With Risk Factors (RF) [Arm A] | In- and outpatients with diagnosis of diabetes, and with diagnosis of risk factors cardiovascular disease (CVD), heart failure (HF), chronic kidney disease (CKD) or at high cardiovascular (CV) risk identified in the Tianjin regional medical database. |
| FG001 | In- and Outpatients: Diabetic Without RF [Arm B] | In- and outpatients with diagnosis of diabetes, but not with diagnosis of risk factors CVD, HF, CKD or at high CV risk identified in the Tianjin regional medical database. |
| FG002 | In- and Outpatients: Non-diabetic With RF [Arm C] | In- and outpatients without diabetes but with diagnosis of risk factors CVD, HF, CKD or at high CV risk identified in the Tianjin regional medical database. |
| FG003 | In- and Outpatients: Non-diabetic Without RF [Arm D] | In- and outpatients without diabetes and without diagnosis of risk factors CVD, HF, CKD or at high CV risk identified in the Tianjin regional medical database. |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study Period 2015 |
| |||||||||||||
| Study Period 2017 |
| |||||||||||||
| Study Period 2019 |
|
Number of participants with at least one recorded International Classification of Disease (ICD) code diagnosis in the Tianjin regional database, Chinese nationality, and baseline information (birth date and sex) in 2015, 2017, and 2019.
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | All in- and Outpatients [Arm A, B, C, D Together] in 2015, 2017, and 2019 | All in- and outpatients with and without diagnosis of diabetes and with and without established risk factors cardiovascular disease (CVD), heart failure (HF), chronic kidney disease (CKD), or at high cardiovascular (CV) risk. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | As per protocol baseline characteristics were calculated by year over all individual participants considering only participants with available data at their last visit. |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Number of Participants With Established Cardiovascular Disease, or Chronic Kidney Disease, or High Cardiovascular Risk | Number of participants with established cardiovascular disease (CVD), chronic kidney disease (CKD), and/or high cardiovascular (CV) risk was calculated as (100%* Number of patients with labels of interested diseases from 2015 to the given year)/ (Number of diabetic or non-diabetic patients from 2015 to the given year). To compare diabetic with non-diabetic patients within a year and across years
Patients with risk factors were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2015, 2017, and 2019 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, groups were combined as per protocol to 'Diabetic Patients [Arm A and B]' and 'Non-Diabetic Patients [Arm C and D]'. Arms were not mutually exclusive. Only patients with available data were included in this analysis. | Posted | Count of Participants | Participants |
On the last visit (1 day) in 2015, 2017, and 2019 data was retrospectively assessed for the last 12 months in 2015, 2017, and 2019.
This is a retrospective non-interventional study based on electronic healthcare records of the Tianjin regional data base containing the information diagnosis of death. Outcome 14, 15 and 16 show the retrospective analysis of number of patients identified as dead by International Classification of Disease (ICD) code and are also reported here. The arms A, B, C, and D were mutually exclusive in each year but not across years. 'Serious' and 'Other Adverse Events' were not collected.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Diabetic Inpatients With Risk Factors (RF) [Arm A Inpatients Only] - in 2015 | Inpatients with diagnosis of diabetes, and with diagnosis of risk factors cardiovascular disease (CVD), heart failure (HF), chronic kidney disease (CKD) or at high cardiovascular (CV) risk identified in the Tianjin regional medical database in 2015. |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Boehringer Ingelheim, Call Center | Boehringer Ingelheim | 1-800-243-0127 | clintriage.rdg@boehringer-ingelheim.com |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Jun 18, 2021 | Jun 14, 2023 | Prot_000.pdf |
| SAP | No | Yes | No | Statistical Analysis Plan | May 13, 2021 | Jun 14, 2023 | SAP_001.pdf |
Not provided
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Last visit in 2015, up to 1 day |
| Mean Age of Inpatients and All Participants (In-and Outpatients) at Their Last Visit in 2017 | The mean age was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2017. The Arms A, B, C, D - inpatients only were mutually exclusive in 2017. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2017, up to 1 day |
| Mean Age of Inpatients and All Participants (In-and Outpatients) at Their Last Visit in 2019 | The mean age was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2019. The Arms A, B, C, D - inpatients only were mutually exclusive in 2019. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2019, up to 1 day |
| Number of Female and Male Inpatients and All Participants (In-and Outpatients) at Their Last Visit in 2015 | The number of female and male was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2015. The Arms A, B, C, D - inpatients only were mutually exclusive in 2015. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2015, up to 1 day |
| Number of Female and Male Inpatients and All Participants (In-and Outpatients) at Their Last Visit in 2017 | The number of female and male was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2017. The Arms A, B, C, D - inpatients only were mutually exclusive in 2017. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2017, up to 1 day |
| Number of Female and Male Inpatients and All Participants (In-and Outpatients) at Their Last Visit in 2019 | The number of female and male was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2019. The Arms A, B, C, D - inpatients only were mutually exclusive in 2019. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2019, up to 1 day |
| Number of Inpatients and All Participants (In-and Outpatients) With Insurance Payment at Their Last Visit in 2015 | The number of participants with insurance payment was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2015. The Arms A, B, C, D - inpatients only were mutually exclusive in 2015. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2015, up to 1 day |
| Number of Inpatients and All Participants (In-and Outpatients) With Insurance Payment at Their Last Visit in 2017 | The number of participants with insurance payment was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2017. The Arms A, B, C, D - inpatients only were mutually exclusive in 2017. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2017, up to 1 day |
| Number of Inpatients and All Participants (In-and Outpatients) With Insurance Payment at Their Last Visit in 2019 | The number of participants with insurance payment was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2019. The Arms A, B, C, D - inpatients only were mutually exclusive in 2019. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2019, up to 1 day |
| Number of Inpatients and All Participants (In-and Outpatients) by Discharge Department at Their Last Visit in 2015 | The number of participants in a particular discharge department was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2015. The Arms A, B, C, D - inpatients only were mutually exclusive in 2015. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses and records in multiple discharge departments simultaneously. Thus, one participant could potentially occur more than once per arm. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2015, up to 1 day |
| Number of Inpatients and All Participants (In-and Outpatients) by Discharge Department at Their Last Visit in 2017 | The number of participants in a particular discharge department was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2017. The Arms A, B, C, D - inpatients only were mutually exclusive in 2017. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses and records in multiple discharge departments simultaneously. Thus, one participant could potentially occur more than once per arm. Thus, one participant could potentially occur more than once per arm. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2017, up to 1 day |
| Number of Inpatients and All Participants (In-and Outpatients) by Discharge Department at Their Last Visit in 2019 | The number of participants in a particular discharge department was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2019. The Arms A, B, C, D - inpatients only were mutually exclusive in 2019. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses and records in multiple discharge departments simultaneously. Thus, one participant could potentially occur more than once per arm. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2019, up to 1 day |
| Number of Deaths in Inpatients and All Participants (In-and Outpatients) at Their Last Visit in 2015 | The number of participants who were diagnosed as dead in 2015 was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2015. The Arms A, B, C, D - inpatients only were mutually exclusive in 2015. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | On the last visit (1 day) in 2015 data was retrospectively assessed for the last 12 months in 2015. |
| Number of Deaths in Inpatients and All Participants (In-and Outpatients) at Their Last Visit in 2017 | The number of participants who were diagnosed as dead in 2017 was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2017. The Arms A, B, C, D - inpatients only were mutually exclusive in 2017. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | On the last visit (1 day) in 2017 data was retrospectively assessed for the last 12 months in 2017. |
| Number of Deaths in Inpatients and All Participants (In-and Outpatients) at Their Last Visit in 2019 | The number of participants who were diagnosed as dead in 2019 was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2019. The Arms A, B, C, D - inpatients only were mutually exclusive in 2019. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | On the last visit (1 day) in 2019 data was retrospectively assessed for the last 12 months in 2019. |
| The Value of Glycated Hemoglobin (HbA1c) in Inpatients and in All Participants (in- and Outpatients) at Their Last Visit in 2015 | The value of glycated hemoglobin (HbA1c) was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2015. The Arms A, B, C, D - inpatients only were mutually exclusive in 2015. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2015, up to 1 day |
| The Value of Glycated Hemoglobin (HbA1c) in Inpatients and in All Participants (in- and Outpatients) at Their Last Visit in 2017 | The value of glycated hemoglobin (HbA1c) was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2017. The Arms A, B, C, D - inpatients only were mutually exclusive in 2017. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2017, up to 1 day |
| The Value of Glycated Hemoglobin (HbA1c) in Inpatients and in All Participants (in- and Outpatients) at Their Last Visit in 2019 | The value of glycated hemoglobin (HbA1c) was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2019. The Arms A, B, C, D - inpatients only were mutually exclusive in 2019. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2019, up to 1 day |
| Concentration of Random Blood Glucose in Inpatients and in All Participants (in- and Outpatients) at Their Last Visit in 2015 | The concentration (Millimole per liter (mmol/L)) of random blood glucose was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2015. The Arms A, B, C, D - inpatients only were mutually exclusive in 2015. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2015, up to 1 day |
| Concentration of Random Blood Glucose in Inpatients and in All Participants (in- and Outpatients) at Their Last Visit in 2017 | The concentration (Millimole per liter (mmol/L)) of random blood glucose was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2017. The Arms A, B, C, D - inpatients only were mutually exclusive in 2017. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2017, up to 1 day |
| Concentration of Random Blood Glucose in Inpatients and in All Participants (in- and Outpatients) at Their Last Visit in 2019 | The concentration (Millimole per liter (mmol/L)) of random blood glucose was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2019. The Arms A, B, C, D - inpatients only were mutually exclusive in 2019. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2019, up to 1 day |
| Serum Creatine Concentration in Inpatients and in All Participants (in- and Outpatients) at Their Last Visit in 2015 | Serum creatine concentration (μmol/L) was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2015. The Arms A, B, C, D - inpatients only were mutually exclusive in 2015. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2015, up to 1 day |
| Serum Creatine Concentration in Inpatients and in All Participants (in- and Outpatients) at Their Last Visit in 2017 | Serum creatine concentration (μmol/L) was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2017. The Arms A, B, C, D - inpatients only were mutually exclusive in 2017. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2017, up to 1 day |
| Serum Creatine Concentration in Inpatients and in All Participants (in- and Outpatients) at Their Last Visit in 2019 | Serum creatine concentration (μmol/L) was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2019. The Arms A, B, C, D - inpatients only were mutually exclusive in 2019. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | Last visit in 2019, up to 1 day |
| COMPLETED |
|
| NOT COMPLETED |
|
| COMPLETED |
|
| NOT COMPLETED |
|
| Mean |
| Standard Deviation |
| Years |
|
| Sex: Female, Male | As per protocol baseline characteristics were calculated by year over all individual participants considering only participants with available data at their last visit. | Count of Participants | Participants |
|
| Race and Ethnicity Not Collected | Race and Ethnicity were not collected from any participant. | Count of Participants | Participants |
|
| up to 5 years (2015 up to 2019) |
|
|
|
| Secondary | Mean Age of Inpatients and All Participants (In-and Outpatients) at Their Last Visit in 2015 | The mean age was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2015. The Arms A, B, C, D - inpatients only were mutually exclusive in 2015. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2015 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2015. Only patients with available data for this outcome were included in this analysis. | Posted | Mean | Standard Deviation | Years | Last visit in 2015, up to 1 day |
|
|
|
| Secondary | Mean Age of Inpatients and All Participants (In-and Outpatients) at Their Last Visit in 2017 | The mean age was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2017. The Arms A, B, C, D - inpatients only were mutually exclusive in 2017. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2017 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2017. Only patients with available data for this outcome were included in this analysis. | Posted | Mean | Standard Deviation | Years | Last visit in 2017, up to 1 day |
|
|
|
| Secondary | Mean Age of Inpatients and All Participants (In-and Outpatients) at Their Last Visit in 2019 | The mean age was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2019. The Arms A, B, C, D - inpatients only were mutually exclusive in 2019. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2019 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2019. Only patients with available data for this outcome were included in this analysis. | Posted | Mean | Standard Deviation | Years | Last visit in 2019, up to 1 day |
|
|
|
| Secondary | Number of Female and Male Inpatients and All Participants (In-and Outpatients) at Their Last Visit in 2015 | The number of female and male was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2015. The Arms A, B, C, D - inpatients only were mutually exclusive in 2015. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2015 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2015. Only patients with available data for this outcome were included in this analysis. | Posted | Count of Participants | Participants | Last visit in 2015, up to 1 day |
|
|
|
| Secondary | Number of Female and Male Inpatients and All Participants (In-and Outpatients) at Their Last Visit in 2017 | The number of female and male was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2017. The Arms A, B, C, D - inpatients only were mutually exclusive in 2017. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2017 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2017. Only patients with available data for this outcome were included in this analysis. | Posted | Count of Participants | Participants | Last visit in 2017, up to 1 day |
|
|
|
| Secondary | Number of Female and Male Inpatients and All Participants (In-and Outpatients) at Their Last Visit in 2019 | The number of female and male was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2019. The Arms A, B, C, D - inpatients only were mutually exclusive in 2019. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2019 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2019. Only patients with available data for this outcome were included in this analysis. | Posted | Count of Participants | Participants | Last visit in 2019, up to 1 day |
|
|
|
| Secondary | Number of Inpatients and All Participants (In-and Outpatients) With Insurance Payment at Their Last Visit in 2015 | The number of participants with insurance payment was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2015. The Arms A, B, C, D - inpatients only were mutually exclusive in 2015. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2015 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2015. Only patients with available data for this outcome were included in this analysis. | Posted | Count of Participants | Participants | Last visit in 2015, up to 1 day |
|
|
|
| Secondary | Number of Inpatients and All Participants (In-and Outpatients) With Insurance Payment at Their Last Visit in 2017 | The number of participants with insurance payment was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2017. The Arms A, B, C, D - inpatients only were mutually exclusive in 2017. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2017 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2017. Only patients with available data for this outcome were included in this analysis. | Posted | Count of Participants | Participants | Last visit in 2017, up to 1 day |
|
|
|
| Secondary | Number of Inpatients and All Participants (In-and Outpatients) With Insurance Payment at Their Last Visit in 2019 | The number of participants with insurance payment was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2019. The Arms A, B, C, D - inpatients only were mutually exclusive in 2019. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2019 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2019. Only patients with available data for this outcome were included in this analysis. | Posted | Count of Participants | Participants | Last visit in 2019, up to 1 day |
|
|
|
| Secondary | Number of Inpatients and All Participants (In-and Outpatients) by Discharge Department at Their Last Visit in 2015 | The number of participants in a particular discharge department was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2015. The Arms A, B, C, D - inpatients only were mutually exclusive in 2015. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses and records in multiple discharge departments simultaneously. Thus, one participant could potentially occur more than once per arm. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2015 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. Inpatients results [Arm A, B, C, D] are reported separately per arm, in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2015. Only patients with available data were included in this analysis. Patients could have records in multiple departments or could not be classified to any given department. | Posted | Number | Participants | Last visit in 2015, up to 1 day |
|
|
|
| Secondary | Number of Inpatients and All Participants (In-and Outpatients) by Discharge Department at Their Last Visit in 2017 | The number of participants in a particular discharge department was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2017. The Arms A, B, C, D - inpatients only were mutually exclusive in 2017. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses and records in multiple discharge departments simultaneously. Thus, one participant could potentially occur more than once per arm. Thus, one participant could potentially occur more than once per arm. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2017 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. Inpatients results [Arm A, B, C, D] are reported separately per arm, in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2017. Only patients with available data were included in this analysis. Patients could have records in multiple departments or could not be classified to any given department. | Posted | Number | Participants | Last visit in 2017, up to 1 day |
|
|
|
| Secondary | Number of Inpatients and All Participants (In-and Outpatients) by Discharge Department at Their Last Visit in 2019 | The number of participants in a particular discharge department was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2019. The Arms A, B, C, D - inpatients only were mutually exclusive in 2019. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses and records in multiple discharge departments simultaneously. Thus, one participant could potentially occur more than once per arm. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2019 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. Inpatients results [Arm A, B, C, D] are reported separately per arm, in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2019. Only patients with available data were included in this analysis. Patients could have records in multiple departments or could not be classified to any given department. | Posted | Number | Participants | Last visit in 2019, up to 1 day |
|
|
|
| Secondary | Number of Deaths in Inpatients and All Participants (In-and Outpatients) at Their Last Visit in 2015 | The number of participants who were diagnosed as dead in 2015 was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2015. The Arms A, B, C, D - inpatients only were mutually exclusive in 2015. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2015 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2015. Only patients with available data for this outcome were included in this analysis. | Posted | Count of Participants | Participants | On the last visit (1 day) in 2015 data was retrospectively assessed for the last 12 months in 2015. |
|
|
|
| Secondary | Number of Deaths in Inpatients and All Participants (In-and Outpatients) at Their Last Visit in 2017 | The number of participants who were diagnosed as dead in 2017 was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2017. The Arms A, B, C, D - inpatients only were mutually exclusive in 2017. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2017 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2017. Only patients with available data for this outcome were included in this analysis. | Posted | Count of Participants | Participants | On the last visit (1 day) in 2017 data was retrospectively assessed for the last 12 months in 2017. |
|
|
|
| Secondary | Number of Deaths in Inpatients and All Participants (In-and Outpatients) at Their Last Visit in 2019 | The number of participants who were diagnosed as dead in 2019 was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2019. The Arms A, B, C, D - inpatients only were mutually exclusive in 2019. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2019 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2019. Only patients with available data for this outcome were included in this analysis. | Posted | Count of Participants | Participants | On the last visit (1 day) in 2019 data was retrospectively assessed for the last 12 months in 2019. |
|
|
|
| Secondary | The Value of Glycated Hemoglobin (HbA1c) in Inpatients and in All Participants (in- and Outpatients) at Their Last Visit in 2015 | The value of glycated hemoglobin (HbA1c) was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2015. The Arms A, B, C, D - inpatients only were mutually exclusive in 2015. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2015 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2015. Only patients with available data for this outcome were included in this analysis. | Posted | Median | Inter-Quartile Range | Percentage of glycated hemoglobin | Last visit in 2015, up to 1 day |
|
|
|
| Secondary | The Value of Glycated Hemoglobin (HbA1c) in Inpatients and in All Participants (in- and Outpatients) at Their Last Visit in 2017 | The value of glycated hemoglobin (HbA1c) was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2017. The Arms A, B, C, D - inpatients only were mutually exclusive in 2017. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2017 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2017. Only patients with available data for this outcome were included in this analysis. | Posted | Median | Inter-Quartile Range | Percentage of glycated hemoglobin | Last visit in 2017, up to 1 day |
|
|
|
| Secondary | The Value of Glycated Hemoglobin (HbA1c) in Inpatients and in All Participants (in- and Outpatients) at Their Last Visit in 2019 | The value of glycated hemoglobin (HbA1c) was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2019. The Arms A, B, C, D - inpatients only were mutually exclusive in 2019. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2019 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2019. Only patients with available data for this outcome were included in this analysis. | Posted | Median | Inter-Quartile Range | Percentage of glycated hemoglobin | Last visit in 2019, up to 1 day |
|
|
|
| Secondary | Concentration of Random Blood Glucose in Inpatients and in All Participants (in- and Outpatients) at Their Last Visit in 2015 | The concentration (Millimole per liter (mmol/L)) of random blood glucose was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2015. The Arms A, B, C, D - inpatients only were mutually exclusive in 2015. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2015 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2015. Only patients with available data for this outcome were included in this analysis. | Posted | Median | Inter-Quartile Range | Millimole per liter (mmol/L) | Last visit in 2015, up to 1 day |
|
|
|
| Secondary | Concentration of Random Blood Glucose in Inpatients and in All Participants (in- and Outpatients) at Their Last Visit in 2017 | The concentration (Millimole per liter (mmol/L)) of random blood glucose was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2017. The Arms A, B, C, D - inpatients only were mutually exclusive in 2017. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2017 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2017. Only patients with available data for this outcome were included in this analysis. | Posted | Median | Inter-Quartile Range | Millimole per liter (mmol/L) | Last visit in 2017, up to 1 day |
|
|
|
| Secondary | Concentration of Random Blood Glucose in Inpatients and in All Participants (in- and Outpatients) at Their Last Visit in 2019 | The concentration (Millimole per liter (mmol/L)) of random blood glucose was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2019. The Arms A, B, C, D - inpatients only were mutually exclusive in 2019. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2019 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2019. Only patients with available data for this outcome were included in this analysis. | Posted | Median | Inter-Quartile Range | Millimole per liter (mmol/L) | Last visit in 2019, up to 1 day |
|
|
|
| Secondary | Serum Creatine Concentration in Inpatients and in All Participants (in- and Outpatients) at Their Last Visit in 2015 | Serum creatine concentration (μmol/L) was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2015. The Arms A, B, C, D - inpatients only were mutually exclusive in 2015. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2015 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2015. Only patients with available data for this outcome were included in this analysis. | Posted | Median | Inter-Quartile Range | Micromole per liter (μmol/L) | Last visit in 2015, up to 1 day |
|
|
|
| Secondary | Serum Creatine Concentration in Inpatients and in All Participants (in- and Outpatients) at Their Last Visit in 2017 | Serum creatine concentration (μmol/L) was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2017. The Arms A, B, C, D - inpatients only were mutually exclusive in 2017. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2017 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2017. Only patients with available data for this outcome were included in this analysis. | Posted | Median | Inter-Quartile Range | Micromole per liter (μmol/L) | Last visit in 2017, up to 1 day |
|
|
|
| Secondary | Serum Creatine Concentration in Inpatients and in All Participants (in- and Outpatients) at Their Last Visit in 2019 | Serum creatine concentration (μmol/L) was calculated for inpatients grouped by their diagnoses category [Arm A, B, C, D - inpatients only] and for all participants [All in- and outpatients] at their last visit in 2019. The Arms A, B, C, D - inpatients only were mutually exclusive in 2019. Patients with risk factors (RF) were patients with diagnosis of CVD, HF, CKD or at high CV risk. Each participant could potentially have multiple diagnoses simultaneously. The data presented for this outcome is an retrospective analysis of electronic healthcare records of the Tianjin regional data base. Participants with diagnoses of interest were identified by International Classification of Disease (ICD) code. | In- and outpatients in 2019 with and without diabetes and with and without diagnosis of risk factors CVD, HF, CKD, and high CV risk. For this outcome, inpatients results [Arm A, B, C, D] are reported separately per arm and in- and outpatients results [All in-and outpatients] are reported over all in- and outpatients and over all arms in 2019. Only patients with available data for this outcome were included in this analysis. | Posted | Median | Inter-Quartile Range | Micromole per liter (μmol/L) | Last visit in 2019, up to 1 day |
|
|
|
| 303 |
| 84,600 |
| 0 |
| 0 |
| 0 |
| 0 |
| EG001 | Diabetic Inpatients Without RF [Arm B Inpatients Only] - in 2015 | Inpatients with diabetes, and without diagnosis of risk factors CVD, HF, CKD or at high CV risk identified in the Tianjin regional medical database in 2015. | 18 | 14,322 | 0 | 0 | 0 | 0 |
| EG002 | Non-diabetic Inpatients With RF [Arm C Inpatients Only] - 2015 | Inpatients without diabetes, and with diagnosis of risk factors CVD, HF, CKD or at high CV risk identified in the Tianjin regional medical database in 2015. | 94 | 21,682 | 0 | 0 | 0 | 0 |
| EG003 | Non-diabetic Inpatients Without RF [Arm D Inpatients Only] - in 2015 | Inpatients without diabetes, and without diagnosis of risk factors CVD, HF, CKD or at high CV risk identified in the Tianjin regional medical database in 2015. | 15 | 6,573 | 0 | 0 | 0 | 0 |
| EG004 | All in- and Outpatients in 2015 = Total in 2015 | This arm combines all inpatients from arms A, B, C, and D, as well as all outpatients identified in the Tianjin regional medical database in 2015. This arm takes into account all cases of both inpatients and outpatients, with and without diabetes, and with or without a diagnosis of risk factors for cardiovascular disease (CVD), heart failure (HF), chronic kidney disease (CKD), or those at high cardiovascular risk, as identified in the Tianjin regional medical database in 2015. | 430 | 398,008 | 0 | 0 | 0 | 0 |
| EG005 | Diabetic Inpatients With Risk Factors (RF) [Arm A Inpatients Only] - in 2017 | Inpatients with diabetes, and with diagnosis of risk factors cardiovascular disease (CVD), heart failure (HF), chronic kidney disease (CKD) or at high cardiovascular (CV) risk identified in the Tianjin regional medical database in 2017. | 504 | 116,799 | 0 | 0 | 0 | 0 |
| EG006 | Diabetic Inpatients Without RF [Arm B Inpatients Only] - in 2017 | Inpatients with diabetes, and without diagnosis of risk factors CVD, HF, CKD or at high CV risk identified in the Tianjin regional medical database in 2017. | 29 | 22,121 | 0 | 0 | 0 | 0 |
| EG007 | Non-diabetic Inpatients With RF [Arm C Inpatients Only] - in 2017 | Inpatients without diabetes, and with diagnosis of risk factors CVD, HF, CKD or at high CV risk identified in the Tianjin regional medical database in 2017. | 141 | 26,955 | 0 | 0 | 0 | 0 |
| EG008 | Non-diabetic Inpatients Without RF [Arm D Inpatients Only] - in 2017 | Inpatients without diabetes, and without diagnosis of risk factors CVD, HF, CKD or at high CV risk identified in the Tianjin regional medical database in 2017. | 30 | 8,908 | 0 | 0 | 0 | 0 |
| EG009 | All in- and Outpatients in 2017 = Total in 2017 | This arm combines all inpatients from arms A, B, C, and D, as well as all outpatients identified in the Tianjin regional medical database in 2017. This arm takes into account all cases of both inpatients and outpatients, with and without diabetes, and with or without a diagnosis of risk factors for cardiovascular disease (CVD), heart failure (HF), chronic kidney disease (CKD), or those at high cardiovascular risk, as identified in the Tianjin regional medical database in 2017. | 704 | 580,958 | 0 | 0 | 0 | 0 |
| EG010 | Diabetic Inpatients With Risk Factors (RF) [Arm A Inpatients Only] - in 2019 | Inpatients with diabetes, and with diagnosis of risk factors cardiovascular disease (CVD), heart failure (HF), chronic kidney disease (CKD) or at high cardiovascular (CV) risk identified in the Tianjin regional medical database in 2019. | 225 | 139,535 | 0 | 0 | 0 | 0 |
| EG011 | Diabetic Inpatients Without RF [Arm B Inpatients Only] - in 2019 | Inpatients with diabetes, and without diagnosis of risk factors CVD, HF, CKD or at high CV risk identified in the Tianjin regional medical database in 2019. | 8 | 21,549 | 0 | 0 | 0 | 0 |
| EG012 | Non-diabetic Inpatients With RF [Arm C Inpatients Only] - in 2019 | Inpatients without diabetes, and with diagnosis of risk factors CVD, HF, CKD or at high CV risk identified in the Tianjin regional medical database in 2019. | 41 | 28,868 | 0 | 0 | 0 | 0 |
| EG013 | Non-diabetic Inpatients Without RF [Arm D Inpatients Only] - in 2019 | Inpatients without diabetes, and without diagnosis of risk factors CVD, HF, CKD or at high CV risk identified in the Tianjin regional medical database in 2019. | 20 | 9,012 | 0 | 0 | 0 | 0 |
| EG014 | All in- and Outpatients in 2019 = Total in 2019 | This arm combines all inpatients from arms A, B, C, and D, as well as all outpatients identified in the Tianjin regional medical database in 2019. This arm takes into account all cases of both inpatients and outpatients, with and without diabetes, and with or without a diagnosis of risk factors for cardiovascular disease (CVD), heart failure (HF), chronic kidney disease (CKD), or those at high cardiovascular risk, as identified in the Tianjin regional medical database in 2019. | 294 | 680,438 | 0 | 0 | 0 | 0 |
Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
| Male |
|
| Male |
|
| Male |
|
| Department of Obstetrics and Gynecology |
|
| Emergency Department |
|
| Department of Mental Health |
|
| Department of Stomatology |
|
| Department of Internal Medicine |
|
| Other departments |
|
| Department of Surgery |
|
| Medical Technical Departments |
|
| Department of Integrated Traditional Chinese and Western Medicine |
|
| Department of Critical Care Medicine |
|
| Department of Obstetrics and Gynecology |
|
| Emergency Department |
|
| Department of Mental Health |
|
| Department of Stomatology |
|
| Department of Internal Medicine |
|
| Other departments |
|
| Department of Surgery |
|
| Medical Technical Departments |
|
| Department of Integrated Traditional Chinese and Western Medicine |
|
| Department of Critical Care Medicine |
|
| Department of Obstetrics and Gynecology |
|
| Emergency Department |
|
| Department of Mental Health |
|
| Department of Stomatology |
|
| Department of Internal Medicine |
|
| Other departments |
|
| Department of Surgery |
|
| Medical Technical Departments |
|
| Department of Integrated Traditional Chinese and Western Medicine |
|
| Department of Critical Care Medicine |
|